Policy | March 14, 2022
Draft policy on medical devices released
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
He was earlier associated with leading industry players like Hindustan Unilever, TATA Communications, Dr. Lal Path Labs, Oncquest and Metropolis Healthcare
Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making
Ritika has also extensively worked with clients such as WHO, GAVI Alliance, USAID, Gilead, Novartis, Sanofi Pasteur
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore
The award recognizes and supports promising women scientists
The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines
Most recently, Rollins was the Chief Information Officer at UnitedHealthcare
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Subscribe To Our Newsletter & Stay Updated
